Results 241 to 250 of about 11,095,042 (285)

A Rare De Novo Missense Mutation in IFT122 Confers a Genetic Susceptibility Factor of Idiopathic Pediatric Uveitis Via Trio‐based Whole‐Exome Sequencing

Advanced Science, EarlyView.
A rare de novo IFT122‐A773E variant is identified in idiopathic pediatric uveitis and shown to exacerbate retinal inflammation and barrier dysfunction. Mechanistically, the variant enhances IFT43 interaction, elevates calcium signaling, and activates the MEK/ERK/FRA1 axis, revealing a previously unrecognized cilia‐associated pathway that may increase ...
Qian Zhou, Jiaxing Huang, Yilin Wang, Xingran Li, Xianyang Liu, Lingyu Dai, Hongshun Li, Qingfeng Wang, Jiangyi Liu, Guannan Su, Wanyun Zhang, Yang Deng, Qingfeng Cao, Yujie Lai, Xiang Luo, Changwei Huang, Ling Chen, Shengping Hou, Peizeng Yang   +18 more
wiley   +1 more source

Effect of intrapleural anti-Vascular Endothelial Growth Factor (VEGF) associated with nab paclitaxel in a murine model of malignant pleural effusion. [PDF]

BMC Cancer
Silva CSR, Teixeira LR, Pereira KR, Figueiredo Braga Colares P, Alvarenga VA, Sales RKB, Roque AC, Marchi E, Mamoni RL, Pagliarelli Acencio MM.   +9 more
europepmc   +1 more source

Chinese Patient Preferences and Trade-Offs for Therapy-Related Attributes of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration: A Discrete Choice Experiment. [PDF]

Patient
Wang H, Zhang J, Li Y, Suo Y, Wang H, Gu Z, Yan H, Wang C, Shao L, Wei W, Jin X.   +10 more
europepmc   +1 more source

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Türkiye: 48-Month Data, BOSPHORUS-DME Study Group Report No. 1. [PDF]

Turk J Ophthalmol
Özal E, Özkaya A, Arıcı M, Korkmaz A, Ermiş S, Çiloğlu Hayat Ş, Karapapak M, Özal SA, Çakır A, Karataş G, Yıldız D, Erdoğan M, Koçak İ, Sayın N, Karabaş VL, Önder Tokuç E, Tiryaki Demir S, Karataş ME, Uçak T, Öztürk M, Demirayak B, Onur İU, Hepokur M.   +22 more
europepmc   +1 more source

"Attenuated" Pulmonary Tumor Thrombotic Microangiopathy on Anti-Vascular Endothelial Growth Factor Treatment: A Case Report. [PDF]

Case Rep Oncol
Ozaki H, Yamaguchi T, Kizawa R, Tanabe Y, Suyama K, Miura Y.   +5 more
europepmc   +1 more source

Intraocular Pressure After Anti-Vascular Endothelial Growth Factor Injection in Eyes With a Mineralized Bruch's Membrane Caused by Pseudoxanthoma Elasticum. [PDF]

Invest Ophthalmol Vis Sci
Raming K, Saltenberger I, Meinke J, Risseeuw S, Mercieca K, Herrmann P, Chang P, Ach T, van Leeuwen R, Ossewaarde-van Norel J, Pfau M, Holz FG, Pfau K.   +12 more
europepmc   +1 more source

Comparative Real-World Efficacy of Anti-Vascular Endothelial Growth Factor Agents in Neovascular Age-Related Macular Degeneration: A Multicenter Retrospective Study.

Ophthalmologica
Berco E, Kozlov Y, Ostrovsky M, Tuli R, Kin Man Lee T, Samocha K, Shcolnik E, Goldfeather Ben Zaken S, Shoham-Hazon N.   +8 more
europepmc   +1 more source

Anti-Vascular Endothelial Growth Factor Treatment Outcomes in Macular Telangiectasia: A Systematic Review.

Ophthalmologica
Sriranganathan A, Grad J, Mihalache A, Popovic MM, Kertes PJ, Kohly R, Muni RH.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid Neovasculopathy

Journal of Ocular Pharmacology and Therapeutics, 2019
Abstract Purpose: To compare the effectiveness of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for pachychoroid neovasculopathy and neovascular age-related macular degeneration (AMD). Methods:
Han Joo Cho
exaly   +3 more sources